Minaga, Kosuke http://orcid.org/0000-0001-5407-7925
Yoshikawa, Tomoe http://orcid.org/0000-0001-5275-2667
Yamashita, Yukitaka http://orcid.org/0000-0002-6347-2756
Akamatsu, Hiroko http://orcid.org/0000-0003-3042-2979
Ikenouchi, Maiko http://orcid.org/0000-0001-5816-5789
Ishii, Tatsuya http://orcid.org/0000-0003-2136-4703
Matsumoto, Hisakazu http://orcid.org/0000-0003-1772-8447
Iwagami, Hiroyoshi http://orcid.org/0000-0002-6312-8541
Nakatani, Yasuki http://orcid.org/0000-0001-7273-1986
Hatamaru, Keiichi http://orcid.org/0000-0001-9061-4361
Takenaka, Mamoru http://orcid.org/0000-0001-7308-4311
Akamatsu, Takuji http://orcid.org/0000-0002-6826-9829
Uenoyama, Yoshito http://orcid.org/0000-0003-4967-0059
Watanabe, Tomohiro http://orcid.org/0000-0001-7781-6305
Ono, Kazuo http://orcid.org/0000-0003-0914-7351
Chiba, Yasutaka
Kudo, Masatoshi http://orcid.org/0000-0002-4102-3474
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparison of the Diagnostic Performance of Newly Designed 21-Gauge and Standard 22-Gauge Aspiration Needles in Patients with Solid Pancreatic Masses
https://doi.org/10.1007/s10620-019-05624-4
Article History
Received: 12 November 2018
Accepted: 9 April 2019
First Online: 22 April 2019
Compliance with ethical standards
:
: Minaga K., Yoshikawa T., Yamashita Y., Akamatsu H., Ikenouchi M., Ishii T., Matsumoto H., Iwagami H., Nakatani Y., Hatamaru K., Takenaka M., Akamatsu T., Uenoyama Y., Watanabe T., Ono K., and Chiba Y. have no conflict of interest or financial ties to disclose. Kudo M. discloses grants from Chugai Pharmaceutical, Otsuka Pharmaceutical, Takeda Pharmaceutical, Taiho Pharma, Sumitomo Dainippon Pharma, Daiichi Sankyo Pharma, MSD, AbbVie INC., Medico’s Hirata INC., Astellas Pharma, and Bristol-Myers Squibb and advisory consulting for Kowa Pharmaceutical, MSD, Bayer Pharma, Ono Pharmaceutical, and Eisai Pharma.